170836 ⎘
Detection or diagnosis of diseases Immunology or allergic disorders
Sub-classes:DIAGNOSIS OF IMMUNE-MEDIATED INFLAMMATORY DISEASES USING MMP12 AS INDICATOR, AND MEDICINE FOR TREATING IMMUNE-MEDIATED INFLAMMATORY DISEASES VIA MMP12 INHIBITION
#2BIOSENSOR SYSTEM FOR DIAGNOSIS OF FAMILIAL MEDITERRANEAN FEVER(FMF) DISEASE
#3PROTEIN BIOMARKERS FOR USE IN LUPUS NEPHRITIS
#4CD11B AGONISTS FOR TREATMENT OF AUTOIMMUNE DISEASE
#5PROGRAMMED CELL DEATH LIGAND 1 (PD-L1) TARGETING POLYPEPTIDE, MOLECULAR IMAGING PROBE, AND USE THEREOF
#6Mass Spectrometry Kit Including a Cross-linked Antibody or Fragment Thereof
#7FISH ALLERGY ANTIGEN
#8COMPOSITIONS, DEVICES, AND METHODS OF PSORIASIS FOOD SENSITIVITY TESTING
#9PREVENTION AND TREATMENT OF CYTOKINE RELEASE SYNDROME AND NEUROTOXICITY ASSOCIATED WITH CAR-T CELL THERAPY
#10Peptides And Method
#11COMPOSITIONS, DEVICES, AND METHODS OF MIGRAINE HEADACHE FOOD SENSITIVITY TESTING
#12USE OF CEREBROSPINAL FLUID-DERIVED ANTI-VIMENTIN IGG AS MARKER IN DIAGNOSIS OF VIMENTIN ANTIBODY-ASSOCIATED ASTROCYTOPATHY
#13METHODS AND COMPOSITIONS FOR TREATING METABOLIC IMBALANCE IN NEURODEGENERATIVE DISEASE
#14METHODS FOR TREATING AND DIAGNOSING SYSTEMIC LUPUS ERYTHEMATOSUS
#15Assays For Detecting Peanut Allergies
#16DIRECT IMMUNOASSAY MEASUREMENT OF AUTOANTIBODIES
#17IMMUNOASSAY METHOD, NON-SPECIFIC REACTION SUPPRESSION METHOD, IMMUNOASSAY REAGENT, IMMUNOASSAY REAGENT KIT, COMPOSITION, NON-SPECIFIC REACTION SUPPRESSING AGENT, AND USE
#18BIOMARKERS FOR ALLERGEN IMMUNOTHERAPY
#19COMPOSITIONS, DEVICES, AND METHODS OF DEPRESSION SENSITIVITY TESTING
#20Methods of Detecting and Preventing Atopic Allergic Diseases
#21SIGNATURE OF TL1A (TNFSF15) SIGNALING PATHWAY
#22APPARATUS FOR PERFORMING IMMUNOMETRIC TESTS
#23ANTI-FCRN ANTIBODIES
#24IMMUNODOMINANT PROTEINS AND FRAGMENTS IN MULTIPLE SCLEROSIS
#25BIOMARKERS
#26Methods of Using Chemical Complementarity Scoring
#27NOVEL ALLERGEN ISOFORM VARIANTS
#28IDENTIFICATION OF PROTHROMBOTIC CONDITIONS
#29SYSTEMS AND METHODS FOR RHEUMATOID ARTHRITIS BIOMARKER DETECTION
#30ALLERGY ANTIGEN AND EPITOPE THEREOF
#31FLUORESCENT PROBE FOR LABELING M1 MACROPHAGES, AND M1 MACROPHAGE MONITORING SYSTEM USING SAME
#32ANTI-NMDA RECEPTOR ANTIBODIES AND METHODS OF USE
#33METHODS OF BLOOD SCREENING
#34METHODS AND MATERIALS FOR IDENTIFYING AND TREATING MEMBRANOUS NEPHROPATHY
#35LATERAL FLOW IMMUNOASSAY FOR MEASURING FUNCTIONAL C1-ESTERASE INHIBITOR (C1-INH) IN PLASMA SAMPLES
#36Methods and Apparatus for Determination of Sensitivity to Wheat
#37MONITORING INFLAMMATION STATUS
#38Methods of Predicting Food Allergy
#39NEWBORN SCREENING FOR PRIMARY IMMUNODEFICIENCIES, CYSTINOSIS, AND WILSON DISEASE
#40METHODS OF IDENTIFYING SUBJECTS RESPONSIVE TO TREATMENT FOR AN AUTOIMMUNE DISEASE AND COMPOSITIONS FOR TREATING THE SAME
#41RECOMBINANT TYPE I ALLERGEN OF ARTEMISIA ANNUA POLLEN, AND PREPARATION METHOD AND USE THEREOF
#42METHOD OF TREATING IGA NEPHROPATHY BY ADMINISTERING ALTERED ANTIBODIES WHICH BIND HUMAN A PROLIFERATION-INDUCING LIGAND (APRIL) PROTEIN
#43ANTIBODIES AGAINST S100A8 AND S100A9, HETERODIMER OF S100A8 AND S100A9, DETECTION KIT AND USE OF THE ANTIBODIES, HETERODIMER AND DETECTION KIT
#44NEW JUNIPER POLLEN PROTEIN
#45MIMOTOPES OF ARA H 2 AND USES OF THE SAME TO DIAGNOSE PEANUT ALLERGIES
#46COMPOSITIONS AND METHODS FOR DIAGNOSING AUTOIMMUNE AQUAPORINOPATHY
#47METHODS AND MATERIALS FOR ASSESSING IMMUNE SYSTEM PROFILES
#48METHOD OF ASSESSING RISK OF PML
#49COMPOSITIONS AND METHODS FOR DETECTING AND TREATMENT OF MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS
#50COMPOSITIONS AND METHODS FOR TREATMENT OF AUTOIMMUNE DISORDERS AND CANCER
#51Methods and compositions for assessing antibody specificities
#52CELIAC DISEASE EPITOPES
#53ALLERGY ANTIGEN AND EPITOPE THEREOF
#54METHODS FOR DETERMINING DPP3 AND THERAPEUTIC METHODS
#55ANTIBODIES
#56METHODS FOR TREATING PATIENTS WITH AN AUTOANTIBODY-MEDIATED DISEASE
#57Biomarker for Regulatory T Cell
#58Psoriasis and Other Autoimmune Diseases Antigen Immune Modulator (AIM) Therapeutic Platform
#59GENETICALLY MODIFIED CELLS FOR ALLOGENEIC CELL THERAPY
#60REAGENTS, METHODS AND KITS FOR DIAGNOSING PRIMARY IMMUNODEFICIENCIES
#61METHODS OF DIAGNOSING, PROGNOSING, AND TREATING MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN (MIS-C) AND SEVERE COVID-19, AND APPARATUSES THEREOF
#62METHOD AND SYSTEM FOR IMPROVING A PHYSIOLOGICAL RESPONSE
#63SCREENING DONOR LUNGS FOR LUNG TRANSPLANTATION
#64MARKER FOR LYMPHOCYTIC ADENOHYPOPHYSITIS AND RELATED DISEASES, AND USE OF THE MARKER
#65METHOD FOR DIAGNOSING CHRONIC URTICARIA
#66BIOMARKERS PREDICTIVE OF CYTOKINE RELEASE SYNDROME
#67Assays For Determining Severity Of Peanut Allergies
#68GENERATION OF HUMAN PEANUT ALLERGEN-SPECIFIC IGE MONOCLONAL ANTIBODIES FOR DIAGNOSTIC AND THERAPEUTIC USE
#69AUTOANTIBODIES FOR USE IN IDENTIFYING DISEASE
#70COMPOSITIONS AND METHODS FOR IDENTIFICATION OF CROSS-REACTIVE ALLERGENIC PROTEINS AND TREATMENT OF ALLERGIES
#71Peptides And Methods For Detecting Egg Allergies
#72APPLICATION OF CRMP2 AND ANTI-CRMP2 ANTIBODY
#73Method of Tracking Maintenance of Immunological Tolerance
#74METHOD OF DETERMINING AN IMMUNOGENIC RESPONSE CHARACTERISTIC OF A CHEMICAL SUBSTANCE
#75RAPID SCREENING METHODS FOR THYROID ASSOCIATED ORBITOPATHY
#76ANTI-ARA H 2 ANTIBODIES AND USES THEREOF
#77Lipid Abnormalities and Association with Atopic Allergic Diseases
#78NEW TREATMENT AND PREVENTION BASED ON NEW METHOD FOR CONTROLLING CELLULAR IMMUNITY
#79Anti-Tetranor-PGDM Monoclonal Antibody and Use Thereof
#80METHODS FOR DETECTING IMMUNE RESPONSE
#81ASSAY
#82METHODS OF PREDICTING AND TREATING IMMUNOTHERAPY TOXICITY BASED ON IMMUNE CELL POPULATIONS
#83COMPOSITIONS AND METHODS FOR IDENTIFICATION OF CROSS-REACTIVE ALLERGENIC PROTEINS AND TREATMENT OF ALLERGIES
#84SOYBEAN ALLERGY ANTIGEN
#85FISH ALLERGY ANTIGEN
#86ALLERGY ANTIGEN AND EPITOPE THEREOF
#87PREDICTION AND TREATMENT OF IMMUNOTHERAPEUTIC TOXICITY
#88PROTOCOL TO MINIMIZE CALCINEURIN INHIBITOR NEPHROTOXICITY
#89Methods and compositions for assessing antibody specificities
#903-(4-((4-(MORPHOLINOMETHYL-BENZYL)OXY)-1 -OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS
#91HUMAN IGE MONOCLONAL ANTIBODIES TO ANTIBODIES TO ALPHA-GAL (GALACTOSE-A-1,3-GALACTOSE) AND USES THEREFOR
#92AUTOANTIBODIES AS BIOMARKERS FOR LIPODYSTROPHY
#93METHOD FOR PREDICTING PATIENT RESPONSE TO CD40-TARGETED THERAPIES
#94EGG ALLERGY ANTIGEN
#95ASSAY FOR DISTINGUISHING BETWEEN SEPSIS AND SYSTEMIC INFLAMMATORY RESPONSE SYNDROME
#96ANTIBODY BINDING HUMAN IL-5R alpha AND USE THEREOF
#97MASS SPECTROMETRY CONTROL DEVICE, MASS SPECTROMETRY DEVICE, MASS SPECTROMETRY METHOD AND PROGRAM
#98SYSTEMS AND METHODS FOR ALLERGEN DETECTION
#99APPARATUS AND METHOD FOR DETECTING AN ANALYTE
#100METHODS FOR TREATING AUTOIMMUNE DISEASE USING BIOCOMPATIBLE BIOABSORBABLE NANOSPHERES
#101Threshold Assays For Cumulative Reactive Doses Of Peanut Antigens
#102ASSAYS AND REAGENTS FOR CHARACTERIZATION OF MHCI PEPTIDE BINDING
#103METHOD FOR DETERMINATION OF BASOPHIL ACTIVATION AND KITS THEREFORE
#104Methods of Determining Immune Response
#105METHODS AND MATERIALS FOR IDENTIFYING AND TREATING MEMBRANOUS NEPHROPATHY
#106METHODS FOR DETECTING PRIMARY IMMUNODEFICIENCY
#107ALLERGIC DISEASE DETERMINATION METHOD AND DETERMINATION SYSTEM
#108BAT ASSAYS FOR IN VITRO DETERMINATION OF ALLERGIC REACTION
#109ALLERGY ANTIGEN AND EPITOPE FOR SAME
#110Therapeutic Substances, their Preparation and Diagnostic Procedure
#111PREDICTION AND TREATMENT OF IMMUNOTHERAPEUTIC TOXICITY
#112Type 1 IFN Assays and Methods of Diagnosis for Susceptibility to and Treatment of Viral Disease and Viral Vaccines, Including Covid -19
#113NMDA RECEPTOR CONSTRUCTS TO DETECT AND ISOLATE NMDAR AUTOANTIBODIES
#114MODIFYING BINDING MOLECULES TO MINIMIZE PRE-EXISITING INTERACTIONS
#115KIT FOR DETECTING DUST MITE COMPONENT-SPECIFIC ANTIBODIES
#116COMPREHENSIVE ANALYSIS OF ANTI-ALLERGEN ANTIBODIES USING PHAGE DISPLAY
#117T Cells That Respond To Patient Neoepitopes
#118Compositions and methods for the removal of biofilms
#119METHOD FOR EVALUATING ALLERGEN INACTIVATORS AND KIT FOR EVALUATING ALLERGEN INACTIVATORS
#120ANTI-PAD2 ANTIBODY FOR TREATING AND EVALUATING AUTOIMMUNE AND INFLAMMATORY DISEASES
#121METHODS FOR TREATING AND DIAGNOSING SYSTEMIC LUPUS ERYTHEMATOSUS
#122ANTIBODIES THAT SPECIFICALLY BIND PEPTIDES ASSOCIATED WITH THE PRIMARY IMMUNODEFICIENCIES: WISKOTT-ALDRICH SYNDROME AND X-LINKED AGAMMAGLOBULINEMIA
#123Methods and compositions for antibody to high affinity receptor for IgE
#124ANTIGEN OF ALLERGY AND EPITOPE THEREOF
#125IMMUNE STATUS BIOMARKERS AND USES THEREFOR
#126METHODS FOR DIAGNOSING IMMEDIATE HYPERSENSITIVY REACTION
#127NON-INVASIVE DETECTION OF SALIVARY AUTOANTIBODIES
#128IN-VITRO DIAGNOSIS OF HISTAMINE INTOLERANCE SYNDROME
#129METHODS FOR DETECTING FOOD ALLERGIES
#130ASSAY FOR PLASMA CELL ASSOCIATED DISEASE
#131Anti-FcRn Antibodies
#132DIAGNOSTICS
#133METHODS AND KITS FOR DETECTING AUTOIMMUNE DISEASES
#134METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING AN ALLERGY OR ANAPHYLAXIS
#135Method for Collecting Data for Predicting Occurrence of Anaphylaxis
#136MATERIALS AND METHODS FOR ASSESSING CANCER RISK AND TREATING CANCER
#137Product and methods useful for modulating and evaluating immune responses
#138METHODS FOR DETECTING A FOOD SPECIFIC IMMUNE RESPONSE
#139COMPOSITION FOR DETERMINATION OF CELL-MEDIATED IMMUNE RESPONSIVENESS
#140Signature of TL1A (TNFSF15) signaling pathway
#141Method of assessing risk of PML
#142Methods and materials for identifying and treating autoimmune GFAP astrocytopathy
#143Biomarker for diagnosing rheumatoid arthritis and uses thereof
#144COMPOSITIONS AND METHODS FOR DETECTING ALLERGEN REACTIVE TH2 CELLS
#145ALLERGY THERAPY
#146Assay to detect and quantitate specific antibodies for various redox forms of HMGB1
#147Method and means for detecting an autoantibody
#148CELIAC DISEASE DIAGNOSIS METHOD
#149METHOD OF IDENTIFYING PEPTIDE ANTIGENS AND USES THEREOF
#150COMPOSITIONS AND METHODS FOR BINDING ANTIBODIES AND INHIBITING NEUTRALIZING ANTIBODIES
#151METHODS AND COMPOSITIONS FOR TREATING METABOLIC IMBALANCE IN NEURODEGENERATIVE DISEASE
#152BOVINE MONOCYTE-DERIVED MACROPHAGE IN CULTURE SYSTEM AND METHODS FOR MEASURING INNATE IMMUNITY
#153NOVEL ALLERGEN
#154Epitope-Based Approach for Allergy Treatments and Inhibitors for Crohn's Disease
#155SYSTEMIC ALLERGIC RESPONSE RISK ASSESSMENT IN PEANUT ORAL IMMUNOTHERAPY
#156RECOMBINANT DEAMIDATED GLIADIN POLYPEPTIDE ANTIGEN, RECOMBINANT ANTIGEN-EXPRESSING GENE, RECOMBINANT EXPRESSION VECTOR, AND PREPARATION METHOD AND APPLICATION THEREOF
#157Compositions and methods for the removal of biofilms
#158Biomarkers for improving nutrion for infants at risk
#159MATERIALS AND METHODS FOR DETECTING AND TREATING AUTOIMMUNE MOVEMENT DISORDERS
#160Systems and methods for rheumatoid arthritis biomarker detection
#161MATERIALS AND METHODS FOR IDENTIFYING AND TREATING EOSINOPHILIC DISORDERS
#162Methods of Screening and Compounds for Adverse Response to an Implant
#163Peptides, Reagents And Methods For Detecting Food Allergy
#164Test strip for milk immunofluorescence assay (IFA) and use thereof
#165Methods of blood screening
#166DETECTION COMPONENT FOR BLOOD GROUP ANTIGENS
#167Detection of human leukocyte antigen-A*32:01 in connection with determining drug reaction with eosinophilia and systemic symptoms (DRESS) and methods of treating bacterial infection in a subject with vancomycin-induced DRESS
#168COMPOSITIONS AND METHODS FOR SUPPRESSING AND/OR TREATING HIV-INFECTION AND/OR A RELATED CLINICAL CONDITION THEREOF
#169Anti-NMDA receptor antibodies and methods of use
#170METHODS AND COMPOSITIONS FOR MODULATING IMMUNE DYSREGULATION
#171METHOD FOR DETECTING ALLERGIC DISEASES
#172Methods of treating chronic disorders with complement inhibitors
#173METHODS OF DETECTING MARKERS FOR INFLAMMATORY CONDITIONS AND FOOD SENSITIVITY IN COMPANION ANIMALS
#174USE OF CD26 AND CD39 AS NEW PHENOTYPIC MARKERS FOR ASSESSING MATURATION OF FOXP3+ T CELLS AND USES THEREOF FOR DIAGNOSTIC PURPOSES
#1753-(4-((4-(morpholinomethyl-benzyl)oxy)-1 -oxoisoindolin-2-yl)piperidine-2,6-dione for the treatment of systemic lupus erythematosus
#176METHODS FOR DETERMINING DRUG EFFICACY FOR THE TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA, MULTIPLE MYELOMA, AND MYELOID CANCERS
#177Methods and materials for assessing immune system profiles
#178Diagnosis of scleroderma
#179PSORIASIS AND OTHER AUTOIMMUNE DISEASES ANTIGEN IMMUNE MODULATOR (AIM) THERAPEUTIC PLATFORM
#180Human antibody having high affinity to human IL-4 receptor alpha
#181DETECTION AND TREATMENT OF IL-17 AND IL-13 RELATED CONDITIONS
#182Microfluidic device and diagnostic methods for allergy testing based on detection of basophil activation
#183OXIDIZED CARDIOLIPIN AS A PRO-INFLAMMATORY FACTOR
#184DIAGNOSTIC BIOMARKERS FOR SHRIMP ALLERGY
#185MULTI-PARAMETER AUTOMATIC BLOOD CELL COUNTING DEVICE
#186Method for the diagnosis of systemic lupus erythematosus (SLE)
#187Anti-IgE antibody specifically binding to membrane-bound IgE antibody of IgE antibody-producing B cells and method for diagnosing and treating allergic symptoms using the same
#188tTG-DGP BIOMARKERS FOR MONITORING CELIAC DISEASE
#189NEWBORN SCREENING FOR PRIMARY IMMUNODEFICIENCIES, CYSTINOSIS, AND WILSON DISEASE
#190Method and products for the diagnosis of a seafood allergy
#191Ratio of immune cells as prognostic indicator of therapeutic success in allergen-specific immunotherapy
#192EGG ALLERGY ANTIGEN
#193BIOMARKERS, COMPOSITIONS, AND METHODS FOR DIAGNOSING AND TREATING SUBJECTS EXPOSED TO PROTEIN/HEPARIN COMPLEXES
#194Detection of glutathionylated proteins
#195TARGETING PATHOGENIC B CELLS IN AUTOIMMUNITY
#196Anti-CXC chemokine receptor antibodies and C-X-C chemokines for the diagnosis of autoimmune disease and graft-versus-host disease
#197Risk of allergy and nutrition to reduce that risk
#198DIAGNOSTIC METHOD FOR SYSTEMIC LUPUS ERYTHEMATOSUS USING SMYD3 AUTOANTIBODY
#199ANUCLEATED CELLS FOR THE TREATMENT OF DISEASES
#200ALLERGY ANTIGEN AND EPITOPE THEREOF
#201Methods for enabling pet ownership
#202PROTEOMIC SCREENING FOR DISEASES
#203PEPTIDE MICROARRAYS AND NOVEL BIOMARKERS FOR CELIAC DISEASE
#204DETECTION OF ALLERGEN EXPOSURE
#205Methods and compositions for treating asthma and allergic diseases
#206METHOD FOR TREATING ASTHMA OR ALLERGIC DISEASE
#207DIAGNOSTIC BLOOD TEST FOR SARCOIDOSIS
#208Immune Monitoring of Neuro-Inflammatory Amyotrophic Lateral Sclerosis (ALS)
#209Methods and Compositions for Regulating an Immune Response
#210Composition for diagnosing allergies to mites, method of diagnosing allergies to mites, and composition for preventing or treating allergies to mites
#211Assays For Detecting Peanut Allergies
#212DIRECT IMMUNOASSAY MEASUREMENT OF AUTOANTIBODIES
#213TEST METHOD FOR OLFACTORY MUCOSA OR OLFACTORY MUCUS IN MAMMALS
#214Method of treating IgA nephropathy by administering altered antibodies which bind human a proliferation-inducing ligand (APRIL) protein
#215METHODS FOR DIAGNOSING, PROGNOSING AND MONITORING TREATMENT FOR THROMBOSIS IN SUBJECTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
#216Method and means for diagnosing and treating allergy
#217ANALYSIS OF SOLUBLE TLR7 IN HUMAN-DERIVED SAMPLE
#218Methods for testing for food allergies and allergens in foods
#219Detection of Interaction Between an Assay Substance and Blood or Blood Components for Immune Status Evaluation and Immune-Related Disease Detection and Diagnosis
#220THERAPEUTIC SUBSTANCES, THEIR PREPARATION AND DIAGNOSTIC PROCEDURE
#221Methods and Systems for Improving Skin Condition
#222METHOD FOR TREATING AUTOIMMUNE DISEASE
#223A NOVEL RAPID INDIVIDUALIZED WHOLE BLOOD CHIP FOR ANTIBIOTIC, DRUG, AND FOOD ALLERGIES
#224IMMUNODOMINANT PROTEINS AND FRAGMENTS IN MULTIPLE SCLEROSIS
#225Methods and compositions for assessing antibody specificities
#226Methods of Detecting and Preventing Atopic Allergic Diseases
#227DIAGNOSTIC TESTS AND METHODS FOR ASSESSING SAFETY, EFFICACY OR OUTCOME OF ALLERGEN-SPECIFIC IMMUNOTHERAPY (SIT)
#228ANTIGEN BINDING PROTEINS WHICH BIND TO THE pMHC HLA-DQ2.5:DQ2.5 PRESENTING A GLIADIN PEPTIDE
#229LEVELS OF BCMA PROTEIN EXPRESSION ON B CELLS AND USE IN DIAGNOSTIC METHODS OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS
#230Nanoallergens and uses thereof
#231LUPUS ANTICOAGULANT (LA) MIXING METHOD AND KIT WITH REDUCED FACTOR DEFICIENCY EFFECT AND REDUCED INHIBITOR INTERFERENCE FOR IDENTIFYING LA ASSOCIATED WITH ANTIPHOSPHOLIPID SYNDROME
#232BIOMARKER FOR PREDICTING EFFECTIVENESS FOR AUTOIMMUNE DISEASE TREATMENT, DIAGNOSTIC KIT, AND USE FOR TREATMENT
#233Synthetic Particle Antibody Compositions And Uses Thereof
#234COMPOSITIONS AND METHODS FOR TREATMENT OF CELIAC DISEASE
#235NEW USE AND METHODS OF MODULATING IMMUNE RESPONSES
#236Methods and compositions for diagnosis and treatment of disorders in patients with elevated levels of CXCL9 and other biomarkers
#237Reagents, methods and kits for diagnosing primary immunodeficiencies
#238DIAGNOSTIC METHOD AND THERAPY
#239Detection of an autoantibody
#240NOVEL EPITOPE OF IMMUNOGLOBULIN E, ANTIBODY BINDING THERETO, AND KIT FOR ANALYZING IMMUNOGLOBULIN E IN SAMPLE CONTAINING SAME
#241Peanut formulations and uses thereof
#242METHOD FOR REGULATING ANTIGEN-SPECIFIC MHC EXPRESSION
#243COMPOSITIONS AND METHODS FOR INDIVIDUALIZED CHARACTERIZATION OF NON-IGE MEDIATED FOOD ALLERGIES
#244METHODS AND COMPOSITIONS FOR ASSESSING ANTIBODY SPECIFICITIES
#245Marker sequences for diagnosing and stratifying systemic sclerosis patients
#246Method for detecting indicator of immune-related disease
#247DIAGNOSTIC FOR SJORGREN'S SYNDROME BASED ON A BIOMARKER
#248Method of assessing risk of PML
#249IMMUNE RECOGNITION MOTIFS
#250Method and products for the diagnosis of a seafood allergy
#251ALLERGY ANTIGEN AND EPITOPE THEREOF
#252MODULATION OF SPLENOCYTES IN CELL THERAPY
#253Methods for determining DPP3 and therapeutic methods
#254IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF
#255AUTOMATED IMMUNOANALYZER SYSTEM FOR PERFORMING DIAGNOSTIC ASSAYS FOR AUTOIMMUNE AND INFECTIOUS DISEASES
#256COMPOSITIONS AND METHODS FOR DETECTING ALLERGENS
#257MRGPRX2/MRGPRB2 EXPRESSING CELL BASED ASSAY TO DETECT PSEUDO-ALLERGIC DRUG REACTIONS AND TO IDENTIFY BLOCKERS TO PREVENT THE ADVERSE REACTIONS
#258HISTAMINE-RELEASING FACTOR (HRF), HRF-RECEPTOR AND METHODS OF MODULATING INFLAMMATION
#2593-(4-((4-(morpholinomethyl-benzyl)oxy)-1 -oxoisoindolin-2-yl)piperidine-2,6-dione for the treatment of systemic lupus erythematosus
#260MHC Peptide Complexes and Uses Thereof in Infectious Diseases
#261Carrier and method for detecting an analyte in dried blood spots
#262Lateral flow immunoassay for measuring functional C1-esterase inhibitor (C1-INH) in plasma samples
#263Predicting the onset of a physiological condition of a subject using a digital biophysical model
#264Methods of treating chronic disorders with complement inhibitors
#265Diagnosis of a neuroautoimmune disease
#266Methods for differential diagnosis of autoimmune diseases
#267Phosphate and tensin homolog (PTEN) for the detection of autoimmune diseases or conditions
#268Prediction and treatment of immunotherapeutic toxicity
#269Identification and monitoring of immunoglobulin J chains
#270Anti-human migration stimulating factor (MSF) and uses thereof
#271POLYNUCLEOTIDE-BINDING PROTEIN FOR USE IN DIAGNOSIS
#272Citrullinated peptides that bind to types of MHC class II and their use on diagnosis and treatment
#273TLR agonist-enhanced in vitro assay of cell mediated immune responsiveness
#274ALLERGY ANTIGEN AND EPITOPE FOR SAME
#275METHODS AND KITS FOR DIAGNOSIS OF FAMILIAL MEDITERRANEAN FEVER
#276Method and Kit for Predicting Susceptibility to Allergic Reaction
#277KIT FOR IN VITRO OR EX VIVO MEASUREMENT OF THE EXPRESSION OF sCD127 IN A BIOLOGICAL SAMPLE
#278COMPOSITIONS AND METHODS FOR TREATING SUBJECTS WITH IMMUNE-MEDIATED DISEASES
#279Biomarkers in autoimmune liver disease
#280Signature of TL1A (TNFSF15) signaling pathway
#281INCOMPATIBLE BLOOD GROUP ANTIGEN FOR CANCER DETECTION AND TREATMENT
#282GP2 isoforms and their use in autoantibody capture
#283Materials and methods for assessing cancer risk and treating cancer
#284KIR3DL2 binding agents
#285Agents and methods for diagnosing fish allergy
#286ALLERGY ANTIGEN AND EPITOPE THEREOF
#287Beta-2-glycoprotein 1 derived peptide and use thereof for treating antiphospholipid syndrome
#288METHODS OF MEASURING UBIQUITIN-LIKE MODIFICATIONS
#289ASSAY FOR DISTINGUISHING BETWEEN SEPSIS AND SYSTEMIC INFLAMMATORY RESPONSE SYNDROME
#290METHODS OF TREATING AUTOIMMUNE AND INFLAMMATORY DISEASES
#291DIAGNOSTIC AND THERAPEUTIC METHODS FOR IRAK4-MEDIATED DISORDERS AND CONDITIONS
#292ASSAY FOR PLASMA CELL ASSOCIATED DISEASE
#293Composition comprising B regulatory cells
#294METHOD AND DEVICE FOR EVALUATING IMMUNE CELLS USING MAGNETIC PARTICLES
#295Humanized antibodies which bind to human APRIL (“a proliferation-inducing ligand”)
#296METHODS AND APPARATUS FOR DETECTION OF GLUTEN SENSITIVITY, AND ITS DIFFERENTIATION FROM CELIAC DISEASE
#297ASSAY FOR C5B-9 DEPOSITION IN COMPLEMENT-ASSOCIATED DISORDERS
#298USE OF HLA GENETIC STATUS TO ASSESS OR SELECT TREATMENT OF CELIAC DISEASE
#299Allergen detection
#300Compositions and methods for allergen detection